apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells. Blood 108: 1346–1352. 11. Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, et al. (2007) Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergis- tically with cisplatin. Mol Cancer 6: 66. 12. Luster TA, Carrell JA, McCormick K, Sun D, Humphreys R (2009) Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib. Mol Cancer Ther 8: 292–302. 1535-7163. 13. Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS (2007) Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. Clin Cancer Res 13: 4556–4564. 14. Smith MR, Jin F, Joshi I (2007) Bortezomib sensitizes non-Hodgkin’s lymphoma cells to apoptosis induced by antibodies to tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors TRAIL-R1 and TRAIL-R2. Clin Cancer Res 13: 5528s–5534s. 15. Lu M, Strohecker A, Chen F, Kwan T, Bosman J, et al. (2008) Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Clin Cancer Res 14: 3168–3176. 16. Gong J, Yang D, Kohanim S, Humphreys R, Broemeling L, et al. (2006) Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies. Mol Cancer Ther 5: 2991–3000. 1535-7163. 17. Nawrocki ST, Carew JS, Douglas L, Cleveland JL, Humphreys R, et al. (2007) Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. Cancer Res 67: 6987–6994. 18. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, et al. (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22: 5506–5507. 19. Mora R, Abschuetz A, Kees T, Dokic I, Joschko N, et al. (2009) TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia. Glia 57: 561–581. 20. Sundararajan R, White E (2001) E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J Virol 75: 7506–7516. 21. Tian C, Murrin LC, Zheng JC (2009) Mitochondrial fragmentation is involved in methamphetamine-induced cell death in rat hippocampal neural progenitor cells. PLoS One 4: e5546. 10.1371/journal.pone.0005546 [doi]. 22. Chen Q, Gong B, Almasan A (2000) Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ 7: 227–233. 23. Yamaguchi H, Paranawithana SR, Lee MW, Huang Z, Bhalla KN, et al. (2002) Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. Cancer Res 62: 466–471. 24. Chen JJ, Chou CW, Chang YF, Chen CC (2008) Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. J Immunol 180: 8030–8039. 25. Lin T, Ding Z, Li N, Xu J, Luo G, et al. (2010) 2-tellurium-bridged {beta}- cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-{kappa}B suppression. Carcinogenesis. bgq234 [pii]; 10.1093/carcin/bgq234 [doi]. 26. Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, et al. (2003) Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene 22: 1653–1662. 27. Brooks AD, Sayers TJ (2005) Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis. Cancer Immunol Immunother 54: 499–505. 28. Hernandez A, Wang QD, Schwartz SA, Evers BM (2001) Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 5: 56–65. 29. Takenaga K (1984) Enhancement of lung-colonizing ability of cloned low- metastatic Lewis lung carcinoma cells by treatment with highly polar compounds. Int J Cancer 34: 83–89. 30. Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, et al. (2000) Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 19: 4604–4610. 31. Seol DW, Li J, Seol MH, Park SY, Talanian RV, et al. (2001) Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Cancer Res 61: 1138–1143. 32. Chaudhari AA, Seol JW, Kim SJ, Lee YJ, Kang HS, et al. (2007) Reactive oxygen species regulate Bax translocation and mitochondrial transmembrane potential, a possible mechanism for enhanced TRAIL-induced apoptosis by CCCP. Oncol Rep 18: 71–76. 33. del MM-S, Corbalan-Garcia S, Gomez-Fernandez JC (2001) Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes. Biochemistry 40: 9983–9992. CHX and Lexa Combination-Induced Apoptosis in HCC 34. Kim S, Lee TJ, Leem J, Choi KS, Park JW, et al. (2008) Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J Cell Biochem 104: 895–907. 35. Nechushtan A, Smith CL, Hsu YT, Youle RJ (1999) Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 18: 2330–2341. 36. Gao F, Hu XY, Xie XJ, Xu QY, Wang YP, et al. (2010) Heat shock protein 90 protects rat mesenchymal stem cells against hypoxia and serum deprivation- induced apoptosis via the PI3K/Akt and ERK1/2 pathways. J Zhejiang Univ Sci B 11: 608–617. 37. Perotti C, Liu R, Parusel CT, Bocher N, Schultz J, et al. (2008) Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation. Breast Cancer Res 10: R94. 38. Zhao C, Wang E (2004) Heat shock protein 90 suppresses tumor necrosis factor alpha induced apoptosis by preventing the cleavage of Bid in NIH3T3 fibroblasts. Cell Signal 16: 313–321. 39. Liu DH, Yuan HY, Cao CY, Gao ZP, Zhu BY, et al. (2007) Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal- regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells. Acta Pharmacol Sin 28: 1907–1913. 40. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, et al. (2006) Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 99: 93–101. 41. Robles AI, Wright MH, Gandhi B, Feis SS, Hanigan CL, et al. (2006) Schedule- dependent synergy between the heat shock protein 90 inhibitor 17-(dimethy- laminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apop- tosis to p53-mutant lymphoma cell lines. Clin Cancer Res 12: 6547–6556. 42. Chopra DP, Menard RE, Januszewski J, Mattingly RR (2004) TNF-alpha- mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 203: 145–154. 43. Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, et al. (2003) Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas. J Pathol 200: 327–335. 44. Mori E, Thomas M, Motoki K, Nakazawa K, Tahara T, et al. (2004) Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL- R1 and TRAIL-R2. Cell Death Differ 11: 203–207. 45. Nesterov A, Ivashchenko Y, Kraft AS (2002) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 21: 1135–1140. 46. Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81: 495–504. 47. Lirdprapamongkol K, Sakurai H, Suzuki S, Koizumi K, Prangsaengtong O, et al. (2010) Vanillin Enhances TRAIL-Induced Apoptosis in Cancer Cells through Inhibition of NF-{kappa}B Activation. In Vivo 24: 501–506. 48. Schutze S, Wiegmann K, Machleidt T, Kronke M (1995) TNF-induced activation of NF-kappa B. Immunobiology 193: 193–203. 49. He S, Chen Y, Chen X, Zhao Y, Wang H, et al. (2005) Antitumor effects of soluble TRAIL in human hepatocellular carcinoma. J Huazhong Univ Sci Technolog Med Sci 25: 51–54. 50. He SQ, Chen Y, Chen XP, Zhang WG, Wang HP, et al. (2003) [Antitumor effects of soluble TRAIL in human hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 25: 116–119. 51. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, et al. (2000) Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 32: 482–490. 52. Abdollahi T, Robertson NM, Abdollahi A, Litwack G (2005) Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells. Apoptosis 10: 1383–1393. 53. Dieterle A, Orth R, Daubrawa M, Grotemeier A, Alers S, et al. (2009) The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Int J Cancer 125: 932–941. 54. Mahalingam D, Keane M, Pirianov G, Mehmet H, Samali A, et al. (2009) Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines. Br J Cancer 100: 1415–1424. 55. Huang F, Nie C, Yang Y, Yue W, Ren Y, et al. (2009) Selenite induces redox- dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic Biol Med 46: 1186–1196. 56. Patsos HA, Greenhough A, Hicks DJ, Al KM, Collard TJ, et al. (2010) The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. Int J Oncol 37: 187–193. 57. Su CC, Lin JG, Li TM, Chung JG, Yang JS, et al. (2006) Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res 26: 4379–4389. 58. Ma Y, Lakshmikanthan V, Lewis RW, Kumar MV (2006) Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin. Mol Cancer Ther 5: 170–178. 59. Hertlein E, Wagner AJ, Jones J, Lin TS, Maddocks KJ, et al. (2010) 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood 116: 45–53. PLoS ONE | www.plosone.org 12 February 2011 | Volume 6 | Issue 2 | e16966